Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-02 | New | $31,449,768 | $31,449,768 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Lodewijk De Vink | Director |
William T. Esrey | Director |
Jessica Hopfield | Director |
Robert Hugin | Director |
Peter J. Millett | Director, Executive |
Marc Prisant | Executive |
Stanley Shuman | Director |